Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


3 Ann Intern Med
2 Clin Infect Dis
1 J Infect Dis
9 Lancet
2 N Engl J Med
1 Nat Med
2 Pediatr Infect Dis J
3 PLoS One
21 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. THORNTON JD, Dixon-Williams S, Huml A, Perzynski A, et al
    A Cross-Sectional Study of SARS-CoV-2 Vaccination Among Employees of an Urban Safety-Net Health Care System.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/M21-1513.

  2. MATHENY M, Maleque N, Channell N, Eisch AR, et al
    Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0250.

  3. WERBEL WA, Boyarsky BJ, Ou MT, Massie AB, et al
    Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0282.


    Covid-19 eradication: stopping transmission between countries.
    BMJ. 2021;373:n1425.

    Clin Infect Dis

  5. CURREN EJ, Shankar MB, Fischer M, Meltzer MI, et al
    Cost effectiveness and impact of a targeted age- and incidence-based West Nile virus vaccine strategy.
    Clin Infect Dis. 2021 Jun 12. pii: 6297173. doi: 10.1093.
    PubMed         Abstract available

  6. POLLETT SD, Richard SA, Fries AC, Simons MP, et al
    The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
    Clin Infect Dis. 2021 Jun 12. pii: 6297424. doi: 10.1093.
    PubMed         Abstract available

    J Infect Dis

  7. DEMONBREUN AR, Sancilio A, Velez ME, Ryan DT, et al
    COVID-19 mRNA vaccination generates greater IgG levels in women compared to men.
    J Infect Dis. 2021 Jun 12. pii: 6297423. doi: 10.1093.
    PubMed         Abstract available


  8. KUPPALLI K, Gala P, Cherabuddi K, Kalantri SP, et al
    India's COVID-19 crisis: a call for international action.
    Lancet. 2021 May 14. pii: S0140-6736(21)01121.

  9. NASSER A, Zakham F
    A strategy for SARS-CoV-2 vaccination in Yemen.
    Lancet. 2021;397:2247.

  10. MCQUADE ETR, Platts-Mills JA
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
    Lancet. 2021;397:2247-2248.

  11. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Lancet. 2021;397:2248.

  12. ROBERTSON JFR, Sewell HF
    COVID-19 vaccine efficacy data: solid enough to delay second dose?
    Lancet. 2021;397:2248-2249.

  13. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Lancet. 2021;397:2249-2250.

  14. SAHA S, Saha SK
    Vaccines can save children with non-preventable diseases.
    Lancet. 2021;397:2250.

  15. GAYTHORPE KAM, Toor J, Echeverria-Londono S, Li X, et al
    Vaccines can save children with non-preventable diseases - Authors' reply.
    Lancet. 2021;397:2251.

  16. GUETL K, Gary T, Raggam RB, Schmid J, et al
    SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
    Lancet. 2021 Jun 11. pii: S0140-6736(21)01238.

    N Engl J Med

  17. MOYO-GWETE T, Madzivhandila M, Makhado Z, Ayres F, et al
    Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104192.

  18. SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
    Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.

    Nat Med

  19. KUSTIN T, Harel N, Finkel U, Perchik S, et al
    Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals.
    Nat Med. 2021 Jun 14. pii: 10.1038/s41591-021-01413.
    PubMed         Abstract available

    Pediatr Infect Dis J

  20. BURNETT E, Parashar UD, Tate JE
    Rotavirus Infection, Illness, and Vaccine Performance in Malnourished Children: A Review of the Literature.
    Pediatr Infect Dis J. 2021 Jun 10. pii: 00006454-900000000-95796.
    PubMed         Abstract available

  21. SANTOS J, Montellano ME, Solante R, Perreras N, et al
    Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines.
    Pediatr Infect Dis J. 2021 Jun 10. pii: 00006454-900000000-95794.
    PubMed         Abstract available

    PLoS One

  22. STUURMAN AL, Ciampini S, Vannacci A, Bella A, et al
    Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.
    PLoS One. 2021;16:e0252836.
    PubMed         Abstract available

  23. STRODEL R, Dayton L, Garrison-Desany HM, Eber G, et al
    COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans.
    PLoS One. 2021;16:e0253208.
    PubMed         Abstract available

  24. LINKS IJ, Denholm LJ, Evers M, Kingham LJ, et al
    Is vaccination a viable method to control Johne's disease caused by Mycobacterium avium subsp. paratuberculosis? Data from 12 million ovine vaccinations and 7.6 million carcass examinations in New South Wales, Australia from 1999-2009.
    PLoS One. 2021;16:e0246411.
    PubMed         Abstract available


  25. KESSELS R, Luyten J, Tubeuf S
    Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00664.
    PubMed         Abstract available

  26. LUTZ CS, Biggerstaff M, Rolfes MA, Lafond KE, et al
    Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00557.
    PubMed         Abstract available

  27. MUHI S, Stinear TP
    Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00700.
    PubMed         Abstract available

  28. DE VRIES LM, Kellerborg KM, Brouwer WBF, van Baal PHM, et al
    Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00699.
    PubMed         Abstract available

  29. STOECKEL F, Carter C, Lyons BA, Reifler J, et al
    Association of vaccine hesitancy and immunization coverage rates in the European Union.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00657.
    PubMed         Abstract available

  30. SUN Y, Jackson K, Dalmon CA, Shapiro BL, et al
    Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00642.
    PubMed         Abstract available

  31. DIAZ-MITOMA F, Popovic V, Spaans JN
    Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac(R), compared with Engerix-B(R) in healthy Asian adults: A phase 3 randomized clinical trial.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00662.
    PubMed         Abstract available

  32. PATEL MK, Bergeri I, Bresee JS, Cowling BJ, et al
    Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00707.
    PubMed         Abstract available

  33. VANDERSLOTT S, Marks T
    Charting mandatory childhood vaccination policies worldwide.
    Vaccine. 2021 Jun 10. pii: S0264-410X(21)00547.
    PubMed         Abstract available

  34. DEY A, Chozhavel Rajanathan TM, Chandra H, Pericherla HPR, et al
    Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00706.
    PubMed         Abstract available

  35. BEAU RENEER Z, Abreu RB, Jamal US, Corn MR, et al
    Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00659.
    PubMed         Abstract available

  36. MESHER D, Thomas SL, Linley E, Edmundson C, et al
    Post-vaccination HPV seroprevalence among female sexual health clinic attenders in England.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00580.
    PubMed         Abstract available

  37. OH SH, Kim SH, Jeon JH, Kim EB, et al
    Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00734.
    PubMed         Abstract available

  38. HSIA J, Zhao G, Lu PJ, Town M, et al
    Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
    PubMed         Abstract available

  39. ODITA CI, Conan A, Smith-Antony M, Battice J, et al
    Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00719.
    PubMed         Abstract available

  40. CHEN Y, Wang Y, Robertson ID, Hu C, et al
    Key issues affecting the current status of infectious diseases in Chinese cattle farms and their control through vaccination.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00673.
    PubMed         Abstract available

  41. HOEHL S, Ciesek S, Graf J, Wicker S, et al
    A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00736.

  42. RAZ A, Keshet Y, Popper-Giveon A, Karkabi MS, et al
    One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
    Vaccine. 2021 Jun 5. pii: S0264-410X(21)00714.

  43. DAL-RE R, Launay O
    Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00703.

  44. CHAUHAN AS, Kapoor I, Rana SK, Kumar D, et al
    Cost effectiveness of typhoid vaccination in India.
    Vaccine. 2021 Jun 10. pii: S0264-410X(21)00713.
    PubMed         Abstract available

  45. DAVIES C, Stoney T, Hutton H, Parrella A, et al
    School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00637.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.